Citius Oncology, Inc. CTOR Increase Decrease In Due To Related Parties
Increase Decrease In Due To Related Parties at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInDueToRelatedParties.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s increase decrease in due to related parties.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s increase decrease in due to related parties?
- Citius Oncology, Inc. (CTOR) reported increase decrease in due to related parties of -$3.27M in Q1 2026.
- How has Citius Oncology, Inc.'s increase decrease in due to related parties changed year-over-year?
- Citius Oncology, Inc.'s increase decrease in due to related parties decreased by 260.0% year-over-year, from $2.05M to -$3.27M.
- What does increase decrease in due to related parties mean?
- Tracks the net change in liabilities owed to related parties, such as affiliates, key management, or parent companies. Fluctuations in this balance reflect the timing of intercompany settlements and the company's reliance on related-party financing or services. Monitoring this is important for assessing potential conflicts of interest and liquidity management.